pharmaceuticals

I was recently chatting to a chap who runs a shop on our local High Street.

Large acquisitions due

2016 saw several blow-ups for large drug companies

New products, strong finances and robust growth were the main talking points at JP Morgan's recent healthcare conference in San Francisco. There were positive signals regarding the fundraising climate, as well as the strength of innovation within the...

Likes healthcare and technology

Pharmaceuticals are 'getting away with murder'

Stock fell 90%

Rallied following Clinton defeat

Central banks have a 'limited hand'

Concerns have been mounting in the run-up to the US election, particularly over Hillary Clinton's proposed clamp down on drug pricing, writes Carl Harald Janson.